EUVIMEDEUVIMED entdecken
Crossref

Efficacy of aprepitant for refractory pruritus in patients with epidermolysis bullosa and atopic dermatitis: A retrospective study

Cheryl J Hartzell iD, Alexandra Szabova, Andrew B Collins, Armand N Morel, Desimir Mijatovic, Kenneth R Goldschneider

Pediatric Dermatology · 2024

DOI: 10.1111/pde.15704 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Dermatology, 2024. Verfasst von Cheryl J Hartzell und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pain Management Center, Cincinnati Children's Hospital, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Aprepitant, Pruritus, Dermatitis, Atopic, Epidermolysis Bullosa. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

At a single‐center pediatric hospital, the neurokinin‐1 receptor antagonist aprepitant was used to treat refractory pruritus in epidermolysis bullosa (EB) and atopic dermatitis (AD).

Methods

Thirty‐seven patients were included (24 EB patients, 13 AD patients), ages 10 months to 37 years.

Results

58% (14/24) of patients with EB and 85% (11/13) of patients with AD reported aprepitant was effective in decreasing their pruritus, with age‐related differences in efficacy observed in EB patients, and access to the medication by insurance denial or availability of the drug as a barrier to use.

Conclusions

Aprepitant shows promise in controlling refractory pruritus in pediatric EB and AD patients and deserves further study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AprepitantPruritusDermatitis, AtopicEpidermolysis BullosaHumansChildRetrospective StudiesMaleFemaleAdolescentChild, PreschoolInfantAdultYoung AdultTreatment OutcomeNeurokinin-1 Receptor Antagonists

Stichwörter der Autor:innen

aprepitantatopic dermatitisepidermolysis bullosapruritusretrospective studies

Substanzen

AprepitantNeurokinin-1 Receptor Antagonists

Autor:innen und Institutionen

  • Pain Management Center, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.

ORCID-Profile: Cheryl J Hartzell

Zitieren

APA

Hartzell, C. J., Szabova, A., Collins, A. B., Morel, A. N., Mijatovic, D., & Goldschneider, K. R. (2024). Efficacy of aprepitant for refractory pruritus in patients with epidermolysis bullosa and atopic dermatitis: A retrospective study. Pediatric Dermatology. https://doi.org/10.1111/pde.15704

Vancouver

Hartzell CJ, Szabova A, Collins AB, Morel AN, Mijatovic D, Goldschneider KR. Efficacy of aprepitant for refractory pruritus in patients with epidermolysis bullosa and atopic dermatitis: A retrospective study. Pediatric Dermatology. 2024. doi:10.1111/pde.15704

BibTeX
@article{Hartzell2024,
  author = {Hartzell, Cheryl J and Szabova, Alexandra and Collins, Andrew B and Morel, Armand N and Mijatovic, Desimir and Goldschneider, Kenneth R},
  title = {Efficacy of aprepitant for refractory pruritus in patients with epidermolysis bullosa and atopic dermatitis: A retrospective study},
  journal = {Pediatric Dermatology},
  year = {2024},
  doi = {10.1111/pde.15704}
}
Kostenlos starten →